Skip to main content

🧬 New era: CRISPR’s medicine 💊

Weekend Reads

Technology in Perspective
12.30.23 | New era: CRISPR's medicine 💊

The gene-editing technology CRISPR has been used to change the genes of human babies, to modify animals, to treat people with sickle-cell disease, and possibly to permanently cure people of HIV. And Vertex Pharmaceuticals that just got approval to sell the first gene-editing treatment in history, for sickle-cell disease, is already looking for an ordinary drug that could take its place.

Plus, navigate the future of technology with confidence with our year end offer: 25% off on annual subscription. Subscribe & save 25% today.
Subscribe & Save 25%
Subscribe & save 25%

Make 2024 the year your keep up with the fast-paced world of technological innovations and their impact on the way you live and work. Subscribe today to save 25% on an annual subscription to MIT Technology Review.

SUBSCRIBE & SAVE 25%

Was this newsletter forwarded to you, and you'd like to see more?

Sign up today →
LinkedIn
Twitter
Facebook
View in browser | This email was sent to manojdole1.InformationTech@blogger.com.

Manage your preferences | Unsubscribe | Terms of Service | Privacy Policy

MIT Technology Review · 196 Broadway, 3rd fl, · Cambridge, MA 02139 · USA

Copyright © 2023 MIT Technology Review, All rights reserved.

Opt out of all promotional emails and newsletters from MIT Technology Review

Comments